Skip to content

Effect of perioperative individualized lung open ventilation strategies on atelectasis in elderly patients after radical prostate cancer surgery: a randomized controlled trial

Effect of perioperative individualized lung open ventilation strategies on atelectasis in elderly patients after radical prostate cancer surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101107
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic cancer

Interventions

individualized lung open ventilation strategy group:Individualized lung open ventilation strategy
Fixed PEEP group and individualized lung open ventilation strategy group:5cm H2O fixed PEEP

Sponsors

The Second Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged 65 years or older undergoing radical prostatic cancer surgery; 2.BMI 18.5~25 kg/m^2; 3.ASA II~III; 4.Moderate and high risk of pulmonary complications (ARISCAT score>=26); 5.Preoperative pulmonary function showed no significant abnormalities, no spinal or thoracic malformations, no difficult airway, asthma, or COPD; 6.The operation time is expected to be >=2h; 7.Volunteer and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Preoperative hypertension was not effectively controlled or poorly controlled (systolic>=180mmHg or diastolic >=110mmHg); 2.Severe respiratory comorbidities (including but not limited to chronic obstructive pulmonary disease, asthma, lung cancer, tuberculosis, etc.); 3.Severe impairment of liver and kidney function; 4.Serious cardiovascular system diseases: such as severe arrhythmia, heart failure, acute coronary syndrome and other underlying diseases; 5.Participated in other clinical studies in the last 3 months; 6.Situations that other researchers found inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Pulmonary ultrasound score;

Secondary

MeasureTime frame
Hemodynamic index;Pulmonary function index;Arterial blood gas index;Pulmonary complication index;Respiratory mechanical index;

Countries

China

Contacts

Public ContactLi Yun

The Second Hospital of Anhui Medical University

759392488@qq.com+86 15105517565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026